208 related articles for article (PubMed ID: 30805561)
1. Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway.
Choi DH; Yang J; Kim YS
Biochem Biophys Rep; 2019 Mar; 17():182-190. PubMed ID: 30805561
[TBL] [Abstract][Full Text] [Related]
2. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
[TBL] [Abstract][Full Text] [Related]
3. Translational signalling, atrogenic and myogenic gene expression during unloading and reloading of skeletal muscle in myostatin-deficient mice.
Smith HK; Matthews KG; Oldham JM; Jeanplong F; Falconer SJ; Bass JJ; Senna-Salerno M; Bracegirdle JW; McMahon CD
PLoS One; 2014; 9(4):e94356. PubMed ID: 24718581
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of caveolin-3-enhanced protein synthesis rather than proteolysis inhibition in C2C12 myoblasts: relationship with myostatin activity.
Hadj Sassi A; Monteil J; Sauvant P; Atgié C
J Physiol Biochem; 2012 Dec; 68(4):683-90. PubMed ID: 22791505
[TBL] [Abstract][Full Text] [Related]
5. Esophageal striated muscle hypertrophy and muscle fiber type transformation in MSTN knockout pigs.
Jin Z; Choe HM; Lv S; Chang S; Yin X
Transgenic Res; 2022 Jun; 31(3):341-349. PubMed ID: 35570234
[TBL] [Abstract][Full Text] [Related]
6. Myostatin-1 Inhibits Cell Proliferation by Inhibiting the mTOR Signal Pathway and MRFs, and Activating the Ubiquitin-Proteasomal System in Skeletal Muscle Cells of Japanese Flounder
Liu J; Pan M; Huang D; Guo Y; Yang M; Zhang W; Mai K
Cells; 2020 Oct; 9(11):. PubMed ID: 33138208
[TBL] [Abstract][Full Text] [Related]
7. IGF1 does not overcome sexual dimorphism of body and muscle size in Mstn-/- mice.
Paul R; Whiteman K; Falconer SJ; Oldham JM; Jeanplong F; Matthews KG; Smith HK; Thomas M; Watson T; McMahon CD
J Endocrinol; 2021 Feb; 248(2):207-220. PubMed ID: 33295877
[TBL] [Abstract][Full Text] [Related]
8. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice.
Miyake M; Hayashi S; Sato T; Taketa Y; Watanabe K; Hayashi S; Tanaka S; Ohwada S; Aso H; Yamaguchi T
Cell Biol Int; 2007 Oct; 31(10):1274-9. PubMed ID: 17590360
[TBL] [Abstract][Full Text] [Related]
9. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
10. IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice.
Hennebry A; Oldham J; Shavlakadze T; Grounds MD; Sheard P; Fiorotto ML; Falconer S; Smith HK; Berry C; Jeanplong F; Bracegirdle J; Matthews K; Nicholas G; Senna-Salerno M; Watson T; McMahon CD
J Endocrinol; 2017 Aug; 234(2):187-200. PubMed ID: 28533420
[TBL] [Abstract][Full Text] [Related]
11. Identification of the minimum region of flatfish myostatin propeptide (Pep45-65) for myostatin inhibition and its potential to enhance muscle growth and performance in animals.
Kim JH; Kim JH; Sutikno LA; Lee SB; Jin DH; Hong YK; Kim YS; Jin HJ
PLoS One; 2019; 14(4):e0215298. PubMed ID: 30998775
[TBL] [Abstract][Full Text] [Related]
12. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptide.
Miao Y; Yang J; Xu Z; Jing L; Zhao S; Li X
Int J Mol Sci; 2015 Apr; 16(4):7976-94. PubMed ID: 25860951
[TBL] [Abstract][Full Text] [Related]
14. The muscle-hypertrophic effect of clenbuterol is additive to the hypertrophic effect of myostatin suppression.
Kim KH; Kim YS; Yang J
Muscle Nerve; 2011 May; 43(5):700-7. PubMed ID: 21462206
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle.
Amirouche A; Durieux AC; Banzet S; Koulmann N; Bonnefoy R; Mouret C; Bigard X; Peinnequin A; Freyssenet D
Endocrinology; 2009 Jan; 150(1):286-94. PubMed ID: 18801898
[TBL] [Abstract][Full Text] [Related]
17. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
18. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.
Gilson H; Schakman O; Kalista S; Lause P; Tsuchida K; Thissen JP
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E157-64. PubMed ID: 19435857
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation.
Retamales A; Zuloaga R; Valenzuela CA; Gallardo-Escarate C; Molina A; Valdés JA
Biochem Biophys Res Commun; 2015 Aug; 464(2):596-602. PubMed ID: 26151859
[TBL] [Abstract][Full Text] [Related]
20. HMEJ-mediated site-specific integration of a myostatin inhibitor increases skeletal muscle mass in porcine.
Li M; Tang X; You W; Wang Y; Chen Y; Liu Y; Yuan H; Gao C; Chen X; Xiao Z; Ouyang H; Pang D
Mol Ther Nucleic Acids; 2021 Dec; 26():49-62. PubMed ID: 34513293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
